Oxygenta Pharmaceutical Ltd — Important, 16-10-2025: Company Update

Oxygenta Pharmaceutical has received a no-objection from BSE for the reclassification of four individuals – Mr. Sai Sudhakar Vankineni, Ms. Snigdha Vankineni, Mr. Sumanth Simha Vankineni, and Mrs. Jhansi Rani Vankineni – from the ‘Promoter/Promoter Group’ to the ‘Public’ shareholder category. This marks a significant change in the company's ownership structure, increasing the public shareholding. The company will now proceed to seek necessary shareholder approval for this reclassification, streamlining its investor relations and public float.